Skip to main content
Log in

Effect of interferon-α on DOI-induced wet-dog shakes in rats

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Acute (1h) intraperitoneal (ip) treatment with interferon (IFN)-α-2a (300IU/g) significantly inhibited wet-dog shakes (WDS) induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane (DOI; 0.5, 1.0mg/kg), which is mediated by serotonin (5-hydroxytryptamine; 5-HT)2 receptor in rats. IFN-α did not affect spontaneous locomotion. The inhibition of DOI (0.5mg/kg)-induced WDS by IFN-α was dose (90–300 IU/g)- and time (1–6 h)-dependent, and was prevented by 30 min pretreatment with naltrexone (NLTX; 1.0mg/kg, ip), an opioid receptor antagonist. Acute (1h) intracerebroventricular (icv) treatment with IFN-α (1,500IU/rat) also inhibited DOI (0.5mg/kg)-induced WDS, and the effect was blocked by NLTX (50μg/rat, icv). These results suggest that IFN-α may modulate 5-HT2 receptor-mediated behavior through opioid receptors in the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CNS :

central nervous system

DOI :

(±)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane

5-HT :

5-hydroxytryptamine (serotonin)

icv :

intracerebroventricular

IFN :

interferon

ip :

intraperitoneal

IU :

international unit

NLTX :

naltrexone

sc :

subcutaneous

WDS :

wet-dog shakes

References

  • Adams F, Fernandez F, Mavligit G (1988) Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities. J Neuro-Oncol 6: 355–359

    Google Scholar 

  • Birmanns B, Saphier D, Abramsky O (1990) α-Interferon modifies cortical EEG activity: dose-dependence and antagonism by naloxone. J Neurol Sci 100: 22–26

    Google Scholar 

  • Blalock JE, Smith EM (1980) Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci USA 77: 5972–5974

    Google Scholar 

  • Blalock JE, Smith EM (1981) Human leukocyte interferon (huIFN-α): potent endorphinlike opioid activity. Biochem Biophys Res Commun 101: 472–478

    Google Scholar 

  • Crnic LS, Segall MA (1992a) Prostaglandins do not mediate interferon-α effects on mouse behavior. Physiol Behav 51: 349–352

    Google Scholar 

  • Crnic LS, Segall MA (1992b) Behavioral effects of mouse interferons-α and -γ and human interferon-α in mice. Brain Res 590: 277–284

    Google Scholar 

  • Dunn AL, Crnic LS (1993) Repeated injections of interferon-α A/D in Balb/c mice: behavioral effects. Brain Behav Immun 7: 104–111

    Google Scholar 

  • Dursun SM, Handley SL (1993) The effects of α2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Br J Pharmacol 109: 1046–1052

    Google Scholar 

  • Fone KCF, Robinson AJ, Marsden CA (1991) Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats. Br J Pharmacol 103: 1547–1555

    Google Scholar 

  • Garssadi SI, Mandi Y, Regely K, Tarodi B, Beladi I (1993) The inhibitory effect of interferon-alpha on the serotonin-induced impairment of human NK cell activity in whole blood. Brain Behav Immun 7: 164–175

    Google Scholar 

  • Gisslinger H, Svoboda T, Clodi M, Gilly B, Ludwig H, Havelec L, Luger A (1993) Interferon-α stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57: 489–495

    Google Scholar 

  • Green AR, O'Shaughnessy K, Hammond M, Schachter M, Grahame-Smith DG (1983) Inhibition of 5-hydroxytryptamine-mediated behavior by the putative 5-HT2 antagonist pirenperone. Neuropharmacology 22: 573–578

    Google Scholar 

  • Gutterman JU, Fine S, Quesada J, Horning SJ, Levine JF, Alexanian R, Bernhardt L, Kramer J, Spiegel H, Colburn W, Trown P, Merigan T, Dziewanowski Z (1982) Recombinant leukocyte α interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann Intern Med 96: 549–556

    Google Scholar 

  • Henco K, Brosius J, Fujisawa A, Fujisawa JI, Haynes JR, Hochstadt J, Kovacic T, Pasek M, Schambock A, Schmid J, Todokoro K, Walchli M, Nagata S, Weissmann C (1985) Structural relationship of human interferon alpha genes and pseudogenes. J Mol Biol 185: 227–260

    Google Scholar 

  • Kanai K, Iwata K, Nakao K, Kako M, Okamoto H (1990) Suppression of hepatitis C virus RNA by interferon-α. Lancet 336: 245

    Google Scholar 

  • Kugaya A, Kagaya A, Uchitomi Y, Motohashi N, Yamawaki S (1995) Inhibition of serotonin-induced Ca2+ mobilization by interleukin-1β in rat C6BU-1 glioma cells. Brain Res 682: 151–156

    Google Scholar 

  • Kuroda Y, Mikuni M, Ogawa T, Takahashi K (1992) Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology 108: 27–32

    Google Scholar 

  • Kusumi I, Koyama T, Yamashita I (1991) Serotonin-stimulated Ca2+ response is increased in blood platelets of depressed patients. Biol Psychiatry 30: 310–312

    Google Scholar 

  • Lee PHK, Obie J, Hong J-S (1989) Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal mu, but not delta or kappa opioid receptors. J Neurosci 9: 692–697

    Google Scholar 

  • Mannering GJ, Deloria LB (1986) The pharmacology and toxicology of the interferons: an overview. Annu Rev Pharmacol Toxicol 26: 455–515

    Google Scholar 

  • McDonald EM, Mann AH, Thomas HC (1987) Interferons as mediators of psychiatric morbidity. Lancet ii: 1175–1178

    Google Scholar 

  • Meyers CA, Scheibel RS, Forman AD (1991) Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41: 672–676

    Google Scholar 

  • Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K (1991) Increased 5-HT2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 15: 49–61

    Google Scholar 

  • Mikuni M, Kagaya A, Takahashi K, Meltzer HY (1992) Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 106: 311–314

    Google Scholar 

  • Muller H, Hammes E, Hiemke C, Hess G (1991) Interferon-alpha-2-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54: 499–503

    Google Scholar 

  • Nakashima T, Hori T, Kuriyama K, Matsuda T (1988) Effects of interferon-α on the activity of preoptic thermosensitive neurons in tissue slices. Brain Res 454: 361–367

    Google Scholar 

  • Okamoto Y, Kagaya A, Shinno H, Motohashi N, Yamawaki S (1995) Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 56: 327–332

    Google Scholar 

  • Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI). Neurosci Lett 115: 74–80

    Google Scholar 

  • Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones EA (1987) Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 147: 1577–1580

    Google Scholar 

  • Roosth J, Pollard RB, Brown SL, Meyer WJ (1986) Cortisol stimulation by recombinant interferon-α2. J Neuroimmunol 12: 311–316

    Google Scholar 

  • Schnittman SM, Vogel S, Baseler M, Lane HC, Davey RT Jr (1994) A phase I study of interferon-α2b in combination with interleukin-2 in patients with human immunodeficiency virus infection. J Infect Dis 169: 981–989

    Google Scholar 

  • Segall MA, Crnic LS (1990) An animal model for the behavioral effects of Interferon. Behav Neurosci 104: 612–618

    Google Scholar 

  • Shibata M, Blatteis CM (1991) Human recombinant tumor necrosis factor and Interferon affect the activity of neurons in the organum vasculosum laminae terminalis. Brain Res 562: 323–326

    Google Scholar 

  • Smedley H, Katrak M, Sikora K, Wheeler T (1983) Neurological effects of recombinant human interferon. Br Med J 286: 262–264

    Google Scholar 

  • Smith MJ, Mouawad R, Vuillemin E, Benhammouda A, Soubrane C, Khayat D (1994) Psychological side effects induced by interleukin-2/α interferon treatment. Psychooncology 3: 289–298

    Google Scholar 

  • Take S, Mori T, Katafuchi T, Hori T (1993) Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am J Physiol 265: R453-R459

    Google Scholar 

  • Terao A, Oikawa M, Saito M (1994) Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am J Physiol 266: R400–R404

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kugaya, A., Kagaya, A., Uchitomi, Y. et al. Effect of interferon-α on DOI-induced wet-dog shakes in rats. J. Neural Transmission 103, 947–955 (1996). https://doi.org/10.1007/BF01291785

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01291785

Keywords

Navigation